COVID-19 early treatment journals

Authors have reported difficulty publishing positive studies for low-cost COVID-19 treatments, with papers being returned without review after months-long delays. We provide analysis of the journals that have published positive studies.

Journals publishing positive low-cost COVID‑19 treatment studies

November 2026

Authors have reported difficulty publishing positive studies for low-cost treatments, with papers being returned without review after months-long delays. These journals have published positive studies. Citation impact is from OpenAlex. Select a column header to sort.

  • Each square is one study
  • Impact, higher is better
Journals publishing positive low-cost COVID-19 treatment studies. Sorted by number of studies.
Treatments
Nutrients
6.45
19 studies
  • Vitamin D14
  • Diet2
  • Exercise1
  • Probiotics1
  • Vitamin C1
Scientific Reports
5.23
18 studies
  • Vitamin D4
  • Metformin3
  • Azvudine2
  • Azithromycin1
  • Diet1
  • H1RAs1
  • HCQ1
  • Indomethacin1
  • Nitric Oxide1
  • Phthalocyan..1
  • Povidone-Iod..1
  • Propolis1
PLOS ONE
3.41
16 studies
  • Colchicine3
  • HCQ3
  • Metformin3
  • Sleep2
  • AgNP1
  • Aspirin1
  • Exercise1
  • Ibuprofen1
  • Ivermectin1
International Journal of Infectious Diseases
2.58
15 studies
  • HCQ5
  • Ivermectin5
  • Ammonium Chloride1
  • Favipiravir1
  • Inosine Pran..1
  • Melatonin1
  • Zinc1
Journal of Clinical Medicine
3.91
13 studies
  • HCQ3
  • Exercise2
  • Antiandrogens1
  • Colchicine1
  • H1RAs1
  • Lactoferrin1
  • Melatonin1
  • NaCl1
  • Sleep1
  • Vitamin D1
Frontiers in Medicine
2.58
13 studies
  • Antiandrogens2
  • Azvudine2
  • Probiotics2
  • Diet1
  • Ivermectin1
  • Nitazoxanide1
  • Povidone-Iod..1
  • Thermotherapy1
  • UDCA1
  • Zinc1
Cureus
1.16
13 studies
  • Ivermectin4
  • Antiandrogens3
  • HCQ2
  • Vitamin C2
  • Famotidine1
  • Metformin1
Frontiers in Pharmacology
5.16
11 studies
  • Azvudine1
  • Camostat1
  • Curcumin1
  • Favipiravir1
  • Fluvoxamine1
  • HCQ1
  • Nigella Sativa1
  • Quercetin1
  • UDCA1
  • Vitamin C1
  • Vitamin D1
BMC Infectious Diseases
3.16
11 studies
  • Ivermectin3
  • HCQ2
  • Azithromycin1
  • Azvudine1
  • Dexamethas..1
  • Diet1
  • Metformin1
  • Vitamin D1
Phytotherapy Research
7.24
10 studies
  • Nigella Sativa4
  • Curcumin3
  • Andrograph..1
  • Colchicine1
  • Propolis1
Journal of Medical Virology
3.50
10 studies
  • Aspirin1
  • Azvudine1
  • Chlorhexidine1
  • HCQ1
  • Ivermectin1
  • Melatonin1
  • Metformin1
  • Montelukast1
  • N-acetylcys..1
  • Nitazoxanide1
Journal of Infection
7.04
9 studies
  • Azvudine2
  • Aspirin1
  • Favipiravir1
  • HCQ1
  • Ivermectin1
  • N-acetylcys..1
  • Nitric Oxide1
  • Vitamin D1
Frontiers in Nutrition
4.45
8 studies
  • Diet5
  • Antiandrogens1
  • Curcumin1
  • Vitamin D1
International Journal of Antimicrobial Agents
4.20
8 studies
  • HCQ4
  • Azithromycin1
  • Ivermectin1
  • Nafamostat1
  • Zinc1
BMJ Open
2.62
8 studies
  • Exercise5
  • Metformin2
  • Zinc1
JAMA Network Open
9.91
7 studies
  • Colchicine2
  • Aspirin1
  • Dexamethas..1
  • Exercise1
  • Fluvoxamine1
  • Sleep1
eClinicalMedicine
12.38
5 studies
  • Azvudine1
  • Camostat1
  • Fluvoxamine1
  • Ivermectin1
  • Nitazoxanide1
Biomedicines
5.28
5 studies
  • Vitamin D2
  • HCQ1
  • Metformin1
  • Probiotics1
Journal of Infection and Public Health
3.92
5 studies
  • Azvudine1
  • Colchicine1
  • Exercise1
  • Favipiravir1
  • Fluvoxamine1
International Journal of Environmental Research and Public Health
3.78
5 studies
  • Vitamin D2
  • Exercise1
  • Lactoferrin1
  • Vitamin C1
Frontiers in Public Health
3.59
5 studies
  • Alkalinization1
  • Exercise1
  • HCQ1
  • Ivermectin1
  • Vitamin D1
Journal of Endocrinological Investigation
3.53
5 studies
  • Vitamin D4
  • Antiandrogens1
Infection and Drug Resistance
2.85
5 studies
  • Azvudine1
  • Diet1
  • Ivermectin1
  • Sleep1
  • Vitamin C1
Open Forum Infectious Diseases
1.21
5 studies
  • HCQ3
  • Favipiravir1
  • Fluvoxamine1
Clinical Infectious Diseases
5.96
4 studies
  • Favipiravir2
  • Metformin1
  • Zinc1
The American Journal of Clinical Nutrition
5.49
4 studies
  • Vitamin D2
  • Diet1
  • Sunlight1
Infectious Diseases and Therapy
5.33
4 studies
  • Exercise1
  • Favipiravir1
  • Ibuprofen1
  • Metformin1
Microorganisms
5.29
4 studies
  • Azvudine1
  • Fluvoxamine1
  • Metformin1
  • UDCA1
Frontiers in Cellular and Infection Microbiology
4.72
4 studies
  • Azvudine3
  • UDCA1
Frontiers in Endocrinology
4.69
4 studies
  • Metformin3
  • Azvudine1
International Journal of General Medicine
2.46
4 studies
  • Quercetin2
  • Colchicine1
  • Iota-carragee..1
Internal and Emergency Medicine
2.09
4 studies
  • HCQ3
  • Vitamin C1
Annals of the Rheumatic Diseases
1.57
4 studies
  • HCQ3
  • Colchicine1
Diabetes Care
13.92
3 studies
  • Metformin3
Heliyon
9.45
3 studies
  • AgNP1
  • Colchicine1
  • HCQ1
Advanced Science
9.41
3 studies
  • Azvudine2
  • N-acetylcys..1
Biomedicine & Pharmacotherapy
8.76
3 studies
  • Metformin1
  • Propolis1
  • Vitamin D1
JAMA Internal Medicine
7.53
3 studies
  • Azelastine1
  • Diet1
  • Metformin1
British Journal of Sports Medicine
6.64
3 studies
  • Exercise3
Inflammopharmacology
5.39
3 studies
  • Antiandrogens1
  • Melatonin1
  • Vitamin C1
BMJ Open Diabetes Research & Care
4.92
3 studies
  • Metformin3
European Journal of Pharmacology
4.73
3 studies
  • Curcumin1
  • Melatonin1
  • Quercetin1
Viruses
4.57
3 studies
  • Favipiravir1
  • H1RAs1
  • Sentinox1
Virology Journal
4.31
3 studies
  • H1RAs1
  • Quercetin1
  • UDCA1
Travel Medicine and Infectious Disease
3.90
3 studies
  • HCQ3
BMC Nutrition
2.98
3 studies
  • Exercise1
  • Probiotics1
  • Zinc1
Archives of Medical Research
2.92
3 studies
  • Aspirin1
  • Melatonin1
  • Vitamin D1
Diabetes Research and Clinical Practice
2.79
3 studies
  • Metformin2
  • HCQ1
BMJ Nutrition, Prevention & Health
2.64
3 studies
  • Diet1
  • Probiotics1
  • Sleep1
Trials
2.42
3 studies
  • Curcumin1
  • Ivermectin1
  • Vitamin A1
The Clinical Respiratory Journal
1.99
3 studies
  • Budesonide1
  • Montelukast1
  • Selenium1
New Microbes and New Infections
1.88
3 studies
  • HCQ2
  • Nitazoxanide1
Archivos de Bronconeumología
1.79
3 studies
  • Aspirin1
  • HCQ1
  • Ivermectin1
COVID
1.10
3 studies
  • Ibuprofen1
  • Resveratrol1
  • Sunlight1
Chest
0.00
3 studies
  • Antiandrogens1
  • Ivermectin1
  • Melatonin1
QJM: An International Journal of Medicine
0.00
3 studies
  • Budesonide1
  • Ivermectin1
  • Vitamin C1
Nature Communications
18.31
2 studies
  • Exercise1
  • Niclosamide1
Gut
11.26
2 studies
  • Diet1
  • Famotidine1
Acta Pharmaceutica Sinica B
10.38
2 studies
  • Azvudine2
European Respiratory Journal
9.12
2 studies
  • Lopinavir/r..1
  • Nitazoxanide1
PLOS Medicine
8.43
2 studies
  • Favipiravir1
  • HCQ1
Pharmaceutics
7.95
2 studies
  • Ivermectin1
  • Xylitol1
Pharmaceuticals
6.26
2 studies
  • H1RAs1
  • Mebendazole1
International Immunopharmacology
6.18
2 studies
  • Favipiravir1
  • HCQ1
Science China Life Sciences
5.56
2 studies
  • HCQ2
Frontiers in Immunology
5.55
2 studies
  • Spirulina1
  • Vitamin C1
Brain, Behavior, and Immunity
5.38
2 studies
  • Exercise2
Diabetes, Obesity and Metabolism
5.36
2 studies
  • Metformin2
RMD Open
5.21
2 studies
  • Colchicine1
  • HCQ1
Journal of Personalized Medicine
5.03
2 studies
  • Alkalinization1
  • Exercise1
Aging
4.85
2 studies
  • Vitamin C1
  • Vitamin D1
BMC Cancer
3.93
2 studies
  • Azvudine1
  • Epigallocatechin Gallate1
Complementary Therapies in Medicine
3.80
2 studies
  • Curcumin1
  • Nigella Sativa1
Healthcare
3.57
2 studies
  • Vitamin D1
  • Zinc1
Medicina
3.56
2 studies
  • Diet1
  • Vitamin D1
The Journal of Steroid Biochemistry and Molecular Biology
3.56
2 studies
  • Vitamin D2
Yonsei Medical Journal
2.72
2 studies
  • Aspirin1
  • Darunavir1
British Journal of Clinical Pharmacology
2.48
2 studies
  • Fluvoxamine1
  • Melatonin1
Journal of General Internal Medicine
2.28
2 studies
  • Metformin1
  • Vitamin D1
Journal of Intensive Care Medicine
2.13
2 studies
  • Aspirin1
  • Budesonide1
Clinical Rheumatology
2.12
2 studies
  • HCQ2
Journal of Physical Activity and Health
2.05
2 studies
  • Exercise2
Medicine
2.04
2 studies
  • Aspirin1
  • Thermotherapy1
Advances in Virology
2.00
2 studies
  • Favipiravir1
  • Mebendazole1
Heart & Lung
2.00
2 studies
  • HCQ1
  • Vitamin B121
IJC Heart & Vasculature
1.97
2 studies
  • HCQ1
  • Metformin1
Annals of Oncology
1.74
2 studies
  • Antiandrogens2
Journal of International Medical Research
1.72
2 studies
  • Ivermectin1
  • N-acetylcys..1
The Journal of Infection in Developing Countries
1.68
2 studies
  • Colchicine1
  • HCQ1
Blood
1.61
2 studies
  • Aspirin1
  • UDCA1
Minerva Medica
1.38
2 studies
  • Probiotics2
Lung India
1.10
2 studies
  • Budesonide1
  • Zinc1
Clinical Nutrition ESPEN
1.07
2 studies
  • Diet1
  • Zinc1
Medicina Clínica
1.06
2 studies
  • Exercise1
  • HCQ1
Indian Journal of Community Medicine
1.01
2 studies
  • HCQ1
  • NaCl1
Pan African Medical Journal
0.96
2 studies
  • HCQ1
  • Vitamin C1
Bratislava Medical Journal
0.94
2 studies
  • Favipiravir1
  • Vitamin D1
Pulmonologiya
0.90
2 studies
  • Exercise1
  • N-acetylcys..1
Gastroenterology
0.72
2 studies
  • Famotidine1
  • N-acetylcys..1
Clinical Infection in Practice
0.62
2 studies
  • Favipiravir1
  • HCQ1
European Journal of Medical and Health Sciences
0.59
2 studies
  • Ivermectin1
  • Spirulina1
Pakistan Journal of Medical and Health Sciences
0.25
2 studies
  • Ivermectin1
  • Nigella Sativa1
The Professional Medical Journal
0.15
2 studies
  • Ivermectin2
Journal of the Indian Medical Association
0.01
2 studies
  • Indomethacin1
  • Ivermectin1

Low-cost treatments and the journals that published them

November 2026

Authors have reported difficulty publishing positive studies for low-cost treatments, with papers being returned without review after months-long delays. This table shows journals that have published positive studies. Citation impact is from OpenAlex.

  • Each square is one study
  • 13.92 Impact, higher is better
Low-cost treatments and the journals that published them. Treatments ranked by number of studies; journals highest impact first.
Treatment Studies Journals
HCQ 56 studies 32 journals
Vitamin D 43 studies 20 journals
Metformin 32 studies 19 journals
Ivermectin 31 studies 21 journals
Exercise 26 studies 17 journals
Azvudine 22 studies 15 journals
Diet 17 studies 12 journals
Favipiravir 14 studies 13 journals
Colchicine 13 studies 10 journals
Vitamin C 12 studies 11 journals
Antiandrogens 12 studies 8 journals
Aspirin 10 studies 10 journals
Zinc 9 studies 9 journals
Melatonin 8 studies 8 journals
Curcumin 8 studies 6 journals
Probiotics 8 studies 6 journals
Fluvoxamine 7 studies 7 journals
Nigella Sativa 7 studies 4 journals
N-acetylcys.. 6 studies 6 journals
UDCA 6 studies 6 journals
Sleep 6 studies 5 journals
H1RAs 5 studies 5 journals
Nitazoxanide 5 studies 5 journals
Quercetin 5 studies 4 journals
Budesonide 4 studies 4 journals
Azithromycin 3 studies 3 journals
Famotidine 3 studies 3 journals
Ibuprofen 3 studies 3 journals
Propolis 3 studies 3 journals
AgNP 2 studies 2 journals
Alkalinization 2 studies 2 journals
Camostat 2 studies 2 journals
Dexamethas.. 2 studies 2 journals
Indomethacin 2 studies 2 journals
Lactoferrin 2 studies 2 journals
Mebendazole 2 studies 2 journals
Montelukast 2 studies 2 journals
NaCl 2 studies 2 journals
Nitric Oxide 2 studies 2 journals
Povidone-Iod.. 2 studies 2 journals
Spirulina 2 studies 2 journals
Sunlight 2 studies 2 journals
Thermotherapy 2 studies 2 journals
Ammonium Chloride 1 study 1 journal
Andrograph.. 1 study 1 journal
Azelastine 1 study 1 journal
Chlorhexidine 1 study 1 journal
Darunavir 1 study 1 journal
Epigallocatechin Gallate 1 study 1 journal
Inosine Pran.. 1 study 1 journal
Iota-carragee.. 1 study 1 journal
Lopinavir/r.. 1 study 1 journal
Nafamostat 1 study 1 journal
Niclosamide 1 study 1 journal
Phthalocyan.. 1 study 1 journal
Resveratrol 1 study 1 journal
Selenium 1 study 1 journal
Sentinox 1 study 1 journal
Vitamin A 1 study 1 journal
Vitamin B12 1 study 1 journal
Xylitol 1 study 1 journal

Journals publishing positive high-profit COVID‑19 treatment studies

November 2026

Journals publishing positive studies of high-profit treatments. Citation impact is from OpenAlex. Select a column header to sort.

  • Each square is one study
  • Impact, higher is better
Journals publishing positive high-profit COVID-19 treatment studies. Sorted by number of studies.
Treatments
Clinical Infectious Diseases
5.96
19 studies
  • Paxlovid6
  • Remdesivir4
  • Ensitrelvir2
  • Tixagev../c..2
  • Ibuzatrelvir1
  • Icatibant1
  • Pemivibart1
  • Sarilumab1
  • Tocilizumab1
New England Journal of Medicine
32.40
15 studies
  • Paxlovid4
  • Tocilizumab2
  • Bamlaniv../e..1
  • Conv. Plasma1
  • Ensitrelvir1
  • Molnupiravir1
  • Peg.. Lambda1
  • Remdesivir1
  • Sarilumab1
  • Tixagev../c..1
  • Xiannuoxin1
Open Forum Infectious Diseases
1.21
10 studies
  • Bamlaniv../e..2
  • Casirivimab/i..2
  • Regdanvimab2
  • Adintrevimab1
  • Ensovibep1
  • Paxlovid1
  • Sargramostim1
The Lancet Infectious Diseases
12.09
7 studies
  • Paxlovid3
  • Deuremidevir1
  • Ensitrelvir1
  • Molnupiravir1
  • Sipavibart1
eClinicalMedicine
12.38
6 studies
  • Leritrelvir2
  • Amubarv../r..1
  • Atilotrelvir1
  • Inhaled Heparin1
  • Tocilizumab1
JAMA
9.53
5 studies
  • Bamlaniv../e..1
  • Casirivimab/i..1
  • Conv. Plasma1
  • P2Y121
  • Sotrovimab1
Infectious Diseases and Therapy
5.33
5 studies
  • Ensitrelvir1
  • Molnupiravir1
  • Regdanvimab1
  • Ropeginterferon alfa-2b1
  • Tocilizumab1
International Journal of Infectious Diseases
2.58
5 studies
  • Bebtelovimab1
  • Casirivimab/i..1
  • Nintedanib1
  • Paxlovid1
  • Regdanvimab1
Cureus
1.16
5 studies
  • Bamlaniv../e..2
  • Proxalutamide2
  • Molnupiravir1
The Lancet
21.04
4 studies
  • Molnupiravir2
  • Casirivimab/i..1
  • Tocilizumab1
Emerging Microbes & Infections
7.48
4 studies
  • Deuremidevir1
  • Molnupiravir1
  • Paxlovid1
  • SA581
The Journal of Infectious Diseases
4.10
4 studies
  • Casirivimab/i..2
  • Remdesivir1
  • Sotrovimab1
NEJM
32.40
3 studies
  • Casirivimab/i..1
  • Conv. Plasma1
  • Remdesivir1
The Lancet Respiratory Medicine
11.52
3 studies
  • Tixagev../c..2
  • Peg.. Lambda1
JAMA Internal Medicine
7.53
3 studies
  • Tocilizumab2
  • Paxlovid1
Journal of Infection
7.04
3 studies
  • Molnupiravir2
  • Paxlovid1
Annals of Internal Medicine
4.96
3 studies
  • Paxlovid2
  • Casirivimab/i..1
Clinical Microbiology and Infection
4.69
3 studies
  • Tocilizumab2
  • Paxlovid1
Viruses
4.57
3 studies
  • Sotrovimab2
  • Remdesivir1
Journal of Antimicrobial Chemotherapy
4.31
3 studies
  • Remdesivir2
  • Paxlovid1
Journal of Clinical Investigation
10.78
2 studies
  • Bamlaniv../e..1
  • Conv. Plasma1
JAMA Network Open
9.91
2 studies
  • Ensitrelvir1
  • Paxlovid1
The Lancet Rheumatology
7.37
2 studies
  • Tocilizumab2
Frontiers in Pharmacology
5.16
2 studies
  • Molnupiravir1
  • Paxlovid1
Journal of Infection and Public Health
3.92
2 studies
  • Paxlovid1
  • Sotrovimab1
Journal of Medical Virology
3.50
2 studies
  • HH-1202
BMC Infectious Diseases
3.16
2 studies
  • Conv. Plasma1
  • Plasma-activ..1
Journal of Korean Medical Science
3.02
2 studies
  • Paxlovid1
  • Regdanvimab1
Journal of Infection and Chemotherapy
1.73
2 studies
  • Casirivimab/i..1
  • Ensitrelvir1
American Journal of Transplantation
0.97
2 studies
  • Paxlovid1
  • Tixagev../c..1